Biotech Values

[go seek]

Then for what reason will MNTA's share price rise?

One would think "concrete feedback on the Lovenox launch at 1:15am ET on 21-Oct-2010" (your msg) #msg-53734778 would be a factor in reducing market uncertainty... and embolden buyers.

Could it be MNTA @ present is oversold? (technicals?)

'Spect we should all admit judgment on why a P/S rises or falls is just that... "speculation"... and sometimes "the analyst" misses parts of the equation. Point in fact... MNTA's recent move back to $14-$15 after approval.

I am still waiting for $45 given MNTA's m-enox was approved as the sole generic Lovenox



Thank you for your efforts!
// long MNTA... time to print a much higher P/S...

my speculation
Momenta Pharmaceuticals has a very bright future.
>> we will see much higher prints in the days ahead